DK2675438T3 - Pulver og vandig suspension med forlænget frigivelse omfattende methylphenidat - Google Patents

Pulver og vandig suspension med forlænget frigivelse omfattende methylphenidat

Info

Publication number
DK2675438T3
DK2675438T3 DK11705137.5T DK11705137T DK2675438T3 DK 2675438 T3 DK2675438 T3 DK 2675438T3 DK 11705137 T DK11705137 T DK 11705137T DK 2675438 T3 DK2675438 T3 DK 2675438T3
Authority
DK
Denmark
Prior art keywords
methylphenidate
victory
suspension
covering
powder
Prior art date
Application number
DK11705137.5T
Other languages
English (en)
Inventor
Ketan Mehta
Yu-Hsing Tu
Ashok Perumal
Original Assignee
Tris Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tris Pharma Inc filed Critical Tris Pharma Inc
Application granted granted Critical
Publication of DK2675438T3 publication Critical patent/DK2675438T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK11705137.5T 2011-02-15 2011-02-15 Pulver og vandig suspension med forlænget frigivelse omfattende methylphenidat DK2675438T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/024873 WO2012112140A1 (en) 2011-02-15 2011-02-15 Extended release powder and aqueous suspension comprising methylphenidate

Publications (1)

Publication Number Publication Date
DK2675438T3 true DK2675438T3 (da) 2019-05-20

Family

ID=44625199

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11705137.5T DK2675438T3 (da) 2011-02-15 2011-02-15 Pulver og vandig suspension med forlænget frigivelse omfattende methylphenidat

Country Status (8)

Country Link
EP (1) EP2675438B1 (da)
AU (2) AU2011359405A1 (da)
BR (1) BR112013020537B1 (da)
CA (1) CA2825991C (da)
DK (1) DK2675438T3 (da)
ES (1) ES2721900T3 (da)
IL (1) IL227734B (da)
WO (1) WO2012112140A1 (da)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11400065B2 (en) 2019-03-01 2022-08-02 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11839597B2 (en) 2016-07-22 2023-12-12 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2018160T3 (da) 2006-03-16 2012-02-06 Tris Pharma Inc Modificeret depotformuleringer indeholdende lægemiddel-ionbytterharpikskomplekser
US8287903B2 (en) 2011-02-15 2012-10-16 Tris Pharma Inc Orally effective methylphenidate extended release powder and aqueous suspension product
WO2013003622A1 (en) 2011-06-28 2013-01-03 Neos Therapeutics, Lp Dosage forms for oral administration and methods of treatment using the same
DK2884961T3 (da) 2012-08-15 2019-04-23 Tris Pharma Inc Methylphenidat-tyggetablet med forlænget frigivelse
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2269679A1 (en) * 1996-12-20 1998-07-02 Warner-Lambert Company Antitussive drugs delivered by partially coated ion exchange resins
US7083808B2 (en) * 1998-12-17 2006-08-01 Euro-Celtique S.A. Controlled/modified release oral methylphenidate formulations
CA2355829A1 (en) * 1999-01-07 2000-07-13 Louise Templeton Multiparticulate oral dosage forms
WO2003020242A1 (en) 2001-08-29 2003-03-13 Srl Technologies, Inc. Sustained release preparations
EP1581196A4 (en) * 2002-12-23 2007-08-22 Celltech Americas Inc ACID LABILIC DRUG COMPOSITIONS
US20050181050A1 (en) * 2004-01-28 2005-08-18 Collegium Pharmaceutical, Inc. Dosage forms using drug-loaded ion exchange resins
DK2018160T3 (da) 2006-03-16 2012-02-06 Tris Pharma Inc Modificeret depotformuleringer indeholdende lægemiddel-ionbytterharpikskomplekser
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11839597B2 (en) 2016-07-22 2023-12-12 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12109186B2 (en) 2016-07-22 2024-10-08 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11896572B2 (en) 2016-07-22 2024-02-13 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11766418B2 (en) 2016-07-22 2023-09-26 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12115143B2 (en) 2016-07-22 2024-10-15 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11826335B2 (en) 2016-07-22 2023-11-28 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12115145B2 (en) 2016-07-22 2024-10-15 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12115144B2 (en) 2016-07-22 2024-10-15 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12097176B2 (en) 2016-07-22 2024-09-24 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12097175B2 (en) 2016-07-22 2024-09-24 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12115142B2 (en) 2016-07-22 2024-10-15 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11400065B2 (en) 2019-03-01 2022-08-02 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Also Published As

Publication number Publication date
IL227734A0 (en) 2013-09-30
WO2012112140A1 (en) 2012-08-23
AU2011359405A1 (en) 2013-08-22
CA2825991C (en) 2019-03-12
BR112013020537B1 (pt) 2021-09-08
IL227734B (en) 2018-08-30
BR112013020537A2 (pt) 2017-09-26
ES2721900T3 (es) 2019-08-06
EP2675438B1 (en) 2019-04-10
AU2017202955A1 (en) 2017-05-25
EP2675438A1 (en) 2013-12-25
AU2017202955B2 (en) 2019-01-03
CA2825991A1 (en) 2012-08-23

Similar Documents

Publication Publication Date Title
DK2675438T3 (da) Pulver og vandig suspension med forlænget frigivelse omfattende methylphenidat
HRP20181310T1 (hr) Novi heterociklički derivati i njihova uporaba
IL236036A0 (en) Pyridinone and pyridizinone derivatives
HK1198433A1 (en) N-acyldipeptide derivatives and their uses n-
GB2488225B (en) Reversible platform and crib therewith
AP4055A (en) Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
PL2686331T3 (pl) Rebaudiozyd b i pochodne
EP2640190A4 (en) MODIFIED NICOTINIC COMPOUNDS AND ASSOCIATED METHODS
HK1198833A1 (en) N-acylpeptide derivatives and their uses n-
EP2739279A4 (en) NEW ANILINE DERIVATIVES AND ITS USE
ZA201308807B (en) Hypertension and hyperuricemia
EP2938415A4 (en) MATERIALS AND METHOD
ZA201400187B (en) Suspension device and seasoning
EP2817004A4 (en) BOUVARDIN DERIVATIVES AND THEIR THERAPEUTIC USES
EP2787810A4 (en) INORGANIC PYROPHOSPHATE AND USES THEREOF
PT2739748T (pt) Gene il22ra2 de susceptibilidade à fibrose e suas utilizações
GB201119443D0 (en) GoWinging Concept and patent
GB201107662D0 (en) Ground-heat pile and pile joint